Skip to main content
GPCR
NASDAQ Life Sciences

Aleniglipron Shows 16.2% Weight Loss at 72 Weeks, CEO Touts Safety and Cost Edge

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$36.78
Mkt Cap
$2.625B
52W Low
$22.7
52W High
$94.9
52W Position info
62% above low
Off High info
61% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

GPCR sits 62% above its 52-week low of $22.7.

Summary

Structure Therapeutics reported Phase 2 extension data for its oral GLP-1 aleniglipron, showing up to 16.2% mean weight loss at 72 weeks with no plateau and low discontinuations after a lower starting dose. CEO Ray Stevens highlighted no drug-related liver injury and lower manufacturing costs versus Novo Nordisk and Lilly. This adds specific efficacy and safety details to the positive clinical update from September 8, reinforcing the drug's competitive profile in the obesity market. The data supports the company's Phase 3 plans and could strengthen its positioning against established injectable GLP-1s.

At the time of this announcement, GPCR was trading at $36.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $22.70 to $94.90. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

GPCR - Latest Insights

GPCR
Nov 11, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $20.95
Real-time Price: $16.87 info
Change: -$4.08 (-19%) info
Market Cap: $1.239B info
GPCR
Nov 09, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.41
Real-time Price: $16.87 info
Change: -$4.54 (-21%) info
Market Cap: $1.239B info
GPCR
Nov 09, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $21.41
Real-time Price: $16.87 info
Change: -$4.54 (-21%) info
Market Cap: $1.239B info
GPCR
Sep 08, 2026, 8:09 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $47.60
Real-time Price: $16.87 info
Change: -$30.73 (-65%) info
Market Cap: $1.239B info
GPCR
Sep 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $47.50
Real-time Price: $16.87 info
Change: -$30.63 (-64%) info
Market Cap: $1.239B info